Vaccine News and Research

Latest Vaccine News and Research

A new vaccine that may delay cancer recurrence

A therapeutic cancer vaccine being co-developed by the Ludwig Institute for Cancer Research and the Australian biotech company CSL Limited successfully induced a comprehensive immune response in patients and appeared to delay cancer recurrence

21 Jul 2004

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

Cancer Research Technology announced today that it has entered into a license agreement granting Genentech, Inc. exclusive worldwide rights to its patent portfolio covering an oncology target discovered in the Molecular Oncology Laboratory (Oxford) of Cancer Research UK.

21 Jul 2004

New book predicts a "vaccine century"

A new book published by the Pan American Health Organization (PAHO) predicts that the 21st century will become the "century of vaccines" thanks to rapid developments in the field of immunization.

21 Jul 2004

Vaccination Week reached 40 Million in 35 countries

An estimated 40 million children and adults throughout the Western Hemisphere received vaccines during the first regionwide Vaccination Week in the Americas, held April 24-30 in 35 countries of the Americas.

21 Jul 2004

Russian scientists incorporate HIV antigen into a tomato

Russian scientists are currently creating a pleasant and harmless vaccine, and edible one at that. So far, they managed to incorporate the protein gene – HIV antigen in tomatoes. The research is supported by International Science and Technology Center.

19 Jul 2004

Results from clinical trial of TA-NIC, therapeutic vaccine for the treatment of nicotine addiction

Xenova Group has announced initial results from the second clinical trial of TA-NIC, the Company's therapeutic vaccine being developed for the treatment of nicotine addiction.

17 Jul 2004

Teen birth rate hits record low and prevalence of overweight among children has increased

The well-being of America's children has shown strong gains in some areas but has declined in others, according to a yearly report by federal agencies compiling statistics on children.

16 Jul 2004

Success of the UK’s national screening programme for cervical cancer

An epidemiological study in this week’s issue of THE LANCET highlights the success of the UK’s national screening programme for cervical cancer introduced in 1988.

15 Jul 2004

Research team developing new defenses against plague and smallpox

Using a federal biodefense grant, a Wake Forest University Baptist Medical Center team will try to develop new approaches to immunizing people against the plague and smallpox, two of the most feared potential agents of bio-terrorism.

15 Jul 2004

Research that directs cancer-killing immune cells against the deadliest brain tumors shows promise

Researchers seeking to direct cancer-killing immune cells against the deadliest brain tumors have three new targets that show promise in laboratory studies and in a Phase I patient trial, according to two articles in the July 15 issue of the journal Cancer Research.

15 Jul 2004

Immunotherapeutic strategy allowing patients to use their own immune system to fight their cancer

Scientists affiliated with the Harvard University Medical School have devised ways of bolstering patients' immune response against kidney and breast cancer.

15 Jul 2004

Strategic analysis of the breast cancer therapeutics pipeline

Strategic partnerships between the pharmaceuticals industry and the biotechnology sector are making breast cancer therapeutics one of the most dynamic segments in the overall oncology market.

15 Jul 2004

Vermont Department of Health reports that a Chittenden County toddler died over the weekend from meningococcal disease

The child, who attended Ed-U-Care Children's Center in Essex Junction, became ill on Saturday night, was taken to the hospital and died early Sunday morning.

13 Jul 2004

More than 20 percent of preschool children lack required immunizations

More than 20 percent of preschool children lack required immunizations, placing them and their classmates at risk for illness, according to a new study based on the federal National Immunization Survey.

12 Jul 2004

Lack of access to information for health workers in resource-poor settings is a major obstacle to achieving the 2015 millennium goals for global health

A Public Health article published online today (9 July 2004) highlights how a lack of access to health information for health workers in resource-poor settings is a major obstacle to achieving the 2015 millennium goals for global health.

12 Jul 2004

Human antibodies that thwart the SARS virus in mice can be mass-produced quickly

Human antibodies that thwart the SARS virus in mice can be mass-produced quickly using a new laboratory technique developed by an international research team collaborating with the National Institute of Allergy and Infectious Diseases (NIAID).

12 Jul 2004

New rotavirus vaccines could reduce mortality from the disease by up to 60 percent

Health officials from 16 countries today asked for budgetary support "to ensure the sustainability of the existing vaccination programs and the introduction of new vaccines," at the conclusion of a global symposium on rotavirus, a diarrheal disease that kills over 600,000 children worldwide every year.

10 Jul 2004

Myriad Genetics awarded a $14.2 million contract for AIDS and hepatitis research

Myriad Genetics has announced that it has been awarded a five-year, $14.2 million contract by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

10 Jul 2004

Recent tuberculosis research holds promise for developing a more effective vaccine

Tuberculosis, a mycobacterium that infects human lungs, still claims the lives of about 2 million people every year. Existing vaccines provide questionable protection, and they can even cause disease in individuals with compromised immune systems.

9 Jul 2004

Emerging infectious diseases will continue to confront society in unpredictable ways as long as humans and microbes co-exist

Emerging infectious diseases, which have shaped the course of humanity and caused incalculable suffering and death, will continue to confront society in unpredictable ways as long as humans and microbes co-exist

9 Jul 2004

Vaccine News and Research

Latest Vaccine News and Research

A new vaccine that may delay cancer recurrence

Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target

New book predicts a "vaccine century"

Vaccination Week reached 40 Million in 35 countries

Russian scientists incorporate HIV antigen into a tomato

Results from clinical trial of TA-NIC, therapeutic vaccine for the treatment of nicotine addiction

Teen birth rate hits record low and prevalence of overweight among children has increased

Success of the UK’s national screening programme for cervical cancer

Research team developing new defenses against plague and smallpox

Research that directs cancer-killing immune cells against the deadliest brain tumors shows promise

Immunotherapeutic strategy allowing patients to use their own immune system to fight their cancer

Strategic analysis of the breast cancer therapeutics pipeline

Vermont Department of Health reports that a Chittenden County toddler died over the weekend from meningococcal disease

More than 20 percent of preschool children lack required immunizations

Lack of access to information for health workers in resource-poor settings is a major obstacle to achieving the 2015 millennium goals for global health

Human antibodies that thwart the SARS virus in mice can be mass-produced quickly

New rotavirus vaccines could reduce mortality from the disease by up to 60 percent

Myriad Genetics awarded a $14.2 million contract for AIDS and hepatitis research

Recent tuberculosis research holds promise for developing a more effective vaccine

Emerging infectious diseases will continue to confront society in unpredictable ways as long as humans and microbes co-exist

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Vaccine News and Research

Latest Vaccine News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in